If these data pan out, this first-in-class antibody might be likened to Herceptin, or Rituxan… a precise treatment that works on malignant cells that have tested positive for the relevant molecule.
A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer